Can you provide the upcoming earnings date for MEDICURE INC?
MEDICURE INC (MPH.CA) will report earnings on 2026-04-27.
MEDICURE INC (MPH.CA) Forecast, Price Target & Analyst Ratings
TSX-V:MPH • CA58469E4085
Current stock price
0.95 CAD
0 (0%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDICURE INC (MPH.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$0.95 to mean target of N/A, Based on 8 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
40.00%
MPH.CA was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about MPH.CA.
In the previous month the buy percentage consensus was at a similar level.
MPH.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 23.065M 6.08% | 21.694M -5.94% | 21.907M 0.98% | |
| EBITDA YoY % growth | 3.248M 399.69% | 1.316M -59.48% | -423K -132.14% | |
| EBIT YoY % growth | 1.193M 147.82% | -854K -171.58% | -2.737M -220.49% | |
| Operating Margin | 5.17% | -3.94% | -12.49% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A